Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol - Scorecard - MDSpire

Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol

  • By

  • Jinyi Fu

  • Yifei Qi

  • Jingyi Zhan

  • Linjing Su

  • Yucong Gao

  • Qingbing Zhou

  • Ying Zhang

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy of Yiqi-Yangyin-Huoxue Granules in Treating Type 2 Diabetes Mellitus and Mitigating Early Vascular Aging: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Study

At a Glance

CategoryDetail
Condition
Key MechanismsRemove unsupported claims.
Target Population
Care Setting

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • remove

          Related Resources & Content

          Original Source(s)

          Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol

          • by Jinyi Fu, Yifei Qi, Jingyi Zhan, Linjing Su, Yucong Gao, Qingbing Zhou, Ying Zhang

          • June 3, 2026

          Related Content

          New Strategies for Managing Diabetic Retinopathy

          The Loan Cap That Could Shrink the Doctor Pipeline

          New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

          Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy